QIAGEN Aktie

43,98EUR
-0,90EUR
-2,01%
28.09.2021
51,52USD
-1,09USD
-2,07%
28.09.2021

WKN: A2DKCH / ISIN: NL0012169213

  Kaufen  
Verkaufen
oder
Werbung

QIAGEN Aktien News

28.09.21
Better Buy: Amgen or All 30 Dow Jones Stocks? (MotleyFool)
27.09.21
Amgen (AMGN) Repatha Gets FDA Nod for Expanded Use in Kids (Zacks)
24.09.21
Roche presents new data at World Muscle Society (WMS) 2021 highlighting new advances for people living with rare neuromuscular disorders (Roche Holding AG)
24.09.21
F. Hoffmann-La Roche Ltd : Roche presents new data at World Muscle Society (WMS) 2021 highlighting new advances for people living with rare neuromuscular disorders (Investegate)
22.09.21
Roche launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to help identify multiple pathogens with overlapping symptoms in patients (Roche Holding AG)
22.09.21
F. Hoffmann-La Roche Ltd : Roche launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to help identify multiple pathogens with overlapping symptoms in patients (Investegate)
20.09.21
Roche (RHHBY) Lung Cancer Drug Gets Positive CHMP Opinion (Zacks)
20.09.21
New Phase III data support the benefit of Roche’s Tecentriq in early-stage lung cancer (Roche Holding AG)
20.09.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
20.09.21
F. Hoffmann-La Roche Ltd : New Phase III data support the benefit of Roche’s Tecentriq in early-stage lung cancer (Investegate)
17.09.21
Roche receives positive CHMP opinion for Gavreto® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer (Roche Holding AG)
17.09.21
F. Hoffmann-La Roche Ltd : Roche receives positive CHMP opinion for Gavreto® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer (Investegate)
15.09.21
Roche opens access to pathology imaging tools to improve patient care (Roche Holding AG)
15.09.21
F. Hoffmann-La Roche Ltd : Roche opens access to pathology imaging tools to improve patient care (Investegate)
15.09.21
Evotec publishes DDup 11 - AI-driven antibody discovery at Evotec (EN, Evotec)
14.09.21
Will Roche Stock Rebound After A 7% Fall In A Week? (Forbes)
14.09.21
Statement of changes in beneficial ownership of securities (rss)
11.09.21
These Promising Clinical Results Could Be Huge for Amgen Investors (MotleyFool)
09.09.21
Amgen Becomes Oversold (Forbes)
09.09.21
Roche signs definitive share purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases (Roche Holding AG)
09.09.21
F. Hoffmann-La Roche Ltd : Roche signs definitive share purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases (Investegate)
08.09.21
Adaptimmune (ADAP) Gains on Deal With Roche for Cell Therapies (Zacks)
07.09.21
: Amgen downgraded to equal weight from overweight at Morgan Stanley (MarketWatch)
07.09.21
Roche to present data from industry leading portfolio at ESMO 2021 showing significant progress in early stage and uncommon cancers (Roche Holding AG)
06.09.21
Evotec partner Bayer: Phase IIb trial shows eliapixant significantly decreases cough frequency in patients with refractory chronic cough (EN, Evotec)
02.09.21
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know (Zacks)
02.09.21
Amgen (AMGN) Down 2.2% Since Last Earnings Report: Can It Rebound? (Zacks)
02.09.21
Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neurodegeneration collaboration (EN, Evotec)
01.09.21
aMoon, Roche pick first two cos for Starfinder Lab program (Globes)
31.08.21
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
30.08.21
Roche (RHHBY) Withdraws Tecentriq for Breast Cancer in the U.S. (Zacks)
27.08.21
Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancer (Roche Holding AG)
27.08.21
Incyte (INCY), MorphoSys Win EC Approval for Lymphoma Drug (Zacks)
27.08.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
25.08.21
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
20.08.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
18.08.21
Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy (Roche Holding AG)
18.08.21
F. Hoffmann-La Roche Ltd : Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy (Investegate)
17.08.21
Roche says arthritis drug authorized to treat hospitalized COVID-19 patients is in short supply (Market Watch)
12.08.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
Seite: 123456789...18

QIAGEN News

QIAGEN News: auf dieser Seite finden Sie alle QIAGEN News und Nachrichten zur QIAGEN Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch QIAGEN News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um QIAGEN News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln